Skip to main content
Livermore
Livermore
ZHEN

Arbutus Biopharma Corp

ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001447028

No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Arbutus Biopharma Corp changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of ABUS: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1672176+11
Shares139.0M63.3K140.6M+1.69M (+1.2%)
Value$625.4M$284.6K$674.9M+$49.7M (+8.0%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Arbutus Biopharma Corp at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to ABUS in Q2 2026
InstitutionSharesValue% of portfolio
Nomura Holdings Inc1,637,081$7.86M0.03%
Arrowstreet Capital, Limited Partnership650,700$3.12M0.00%
Mackenzie Financial Corp613,806$2.95M0.00%
Los Angeles Capital Management LLC602,008$2.89M0.01%
Jupiter Topco LLC597,423$2.87M0.00%
Man Group plc473,467$2.27M0.00%
CenterBook Partners LP445,151$2.14M0.10%
Squarepoint Ops LLC208,145$999.1K0.00%
Martingale Asset Management L P193,100$926.9K0.02%
STRS Ohio168,900$810.7K0.00%
Two Sigma Investments, LP84,986$407.9K0.00%
Integrated Quantitative Investments LLC79,937$383.7K0.06%
American Century Companies Inc66,215$317.8K0.00%
Jump Financial, LLC53,162$255.2K0.00%
Allstate Corp44,226$212.3K0.00%
Gsa Capital Partners LLP44,082$212.0K0.01%
Quadrature Capital Ltd42,004$201.6K0.00%
Virginia Retirement Systems Et Al41,800$200.6K0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH39,474$189.5K0.00%
Mitsubishi UFJ Trust & Banking Corp31,688$152.1K0.00%
Axq Capital, LP25,055$120.3K0.01%
Lazard Asset Management LLC23,722$113.9K0.00%
Two Sigma Securities, LLC23,470$112.7K0.01%
Voleon Capital Management LP19,741$94.8K0.00%
Dynamic Technology Lab Private Ltd15,604$75.0K0.02%
Ameriprise Financial Inc10,467$50.2K0.00%
Stoneridge Investment Partners LLC10,125$44.0K0.03%
Federated Hermes, Inc.4,041$19.4K0.00%
Pacer Advisors, Inc.1,706$8.00K0.00%
Caitong International Asset Management Co., Ltd1,363$6.54K0.00%
Quarry LP318$1.53K0.00%
Rialto Wealth Management, LLC116$5570.00%
Clearstead Advisors, LLC25$1200.00%

Sold out (22)

Institutions that held Arbutus Biopharma Corp at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ABUS in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Adage Capital Partners GP, L.L.C.2,664,941$12.0M
Millennium Management LLC642,448$2.89M
Raymond James Financial Inc191,355$861.1K
Balyasny Asset Management LLC125,521$564.8K
Avidity Partners Management LP125,000$562.5K
Schroder Investment Management Group121,313$521.6K
DRW Securities, LLC69,089$310.9K
Group One Trading, L.P.50,843$228.8K
Inceptionr LLC32,580$146.6K
Prelude Capital Management, LLC25,318$113.9K
ExodusPoint Capital Management, LP23,554$106.0K
Freestone Grove Partners LP18,006$81.0K
Gotham Asset Management, LLC17,321$77.9K
Simplex Trading, LLC15,574$70.1K
CIBC Asset Management Inc14,382$64.7K
Pathstone Holdings, LLC10,000$45.0K
Optiver Holding B.V.669$3.01K
MAI Capital Management655$2.95K
Root Financial Partners, LLC281$1.26K
Quadrant Capital Group LLC277$1.25K
Farther Finance Advisors, LLC117$529
Hughes Financial Services, LLC1$5

Not filed for Q2 2026 yet (2)

Institutions that held Arbutus Biopharma Corp at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ABUS in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC60,900$273.7K
CWM, LLC2,423$10.9K